v3.25.2

Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 3,326	$ 2,594
Prepaid expenses and other current assets	35	78
Total assets	4,161	2,672
Current Liabilities:
Warrant liability	0	16
Total current liabilities	1,329	816
Total liabilities	1,329	816
Commitments and contingencies (Note 6)
Stockholders’ equity
Preferred stock	0	0
Common shares, 3,183,558 and 2,108,670 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	0	0
Additional paid-in capital	108,155	105,377
Accumulated deficit	(104,097)	(102,580)
Total stockholders’ equity attributed to the Company	4,058	2,797
Non-controlling interests	(1,226)	(941)
Total stockholders’ equity	2,832	1,856
Total liabilities and stockholders’ equity	4,161	2,672
Nonrelated Party [Member]
Current Liabilities:
Accounts payable and accrued expenses	952	654
Related Party [Member]
Current Liabilities:
Accounts payable and accrued expenses	377	146
AnnJi [Member]
Current assets:
Receivable per license termination and transfer agreement	$ 800	$ 0

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

AVENUE THERAPEUTICS, INC. 10-Q